The verdictThe operating business looks healthier than three days of research suggested last time: backlog, revenue-share income and Legend's earn-out tracking all point the right way, and nothing in the last two months broke the guidance. The bet is still on Q4-26 cash, on how the Legend earn-out is settled, and on the 2029-30 rights renewals. At a ~$5.7 share price, the settlement method has become the most important…
Written by Claude (Anthropic’s AI) from public sources · Willem owns GENI · AI can make mistakes — numbers in brackets point to the sources · Not financial advice
Bull arguments show how well they survive the devil’s advocate (strong / medium / weak); bear arguments show the damage they could do after the counter-argument (high / medium / low).
(Dive #1's Bull #7, insider buying at the lows, has been removed. Locke's 800k-share sale and collar in September 2026 cancel it out; see Bear #7.)
Prediction-market minimums scale well beyond the "prudent" amount in guidance — 37% chance within 36 months · Impact if it happens: Medium
What it is: Kalshi, Polymarket and further "tier-one operators" Locke hinted at sign larger minimums, adding $30m or more of EBITDA (JPMorgan's maturity estimate) [4,22].
Why it's not priced in: Guidance includes only a "prudent", undisclosed amount. The NFL is explicitly excluded [4].
What would trigger it / the sign to watch: a named new prediction-market customer, or a quantified prediction-market revenue line in Q3/Q4-26 results.
Why this probability: The deals exist and are structured with minimums, but Sportradar's slow closes and the unresolved Supreme Court question cap the odds below even.
Legend outperforms and earns its full earn-out with visible synergies — 48% chance · Impact: Medium
What it is: Legend hits the profit and cash thresholds, and cross-selling (BetVision on Legend, prediction-market customer acquisition) shows up in Media growth.
Why it's not priced in: Legend's numbers are undisclosed. At ~7× guided EBITDA the market is pricing it like a declining affiliate.
What would trigger it / the sign to watch: further earn-out remeasurement losses, or a Legend revenue disclosure in the FY26 20-F.
Why this probability: The first remeasurement was upward, but one quarter is thin and the peer group is shrinking, so just under a coin-flip.
The NFL licenses prediction markets and routes the data through Genius — 20% chance · Impact: High
What it is: The NFL signs prediction-market deals like MLB and NHL did, with Genius as the data and settlement partner.
Why it's not priced in: Locke said the NFL is "not and never has been" in the numbers and not to expect it "this season" [4].
What would trigger it / the sign to watch: a Supreme Court or CFTC outcome that settles jurisdiction; an NFL announcement before the 2027 season.
Why this probability: Lowered from 27%. The NFL's 2026-10-08 brief treats these contracts as gambling to be regulated by states, which makes a near-term NFL deal less likely.
A large new US state legalises mobile betting (e.g. Texas in the 2027 session) — 15% chance · Impact: Low
What it is: New state handle flows to Genius customers.
Why it's not priced in: No path in 2026. The next Texas window is the 2027 session [28].
What would trigger it / the sign to watch: a bill passing a Texas or California chamber.
Why this probability: Texas has failed repeatedly, and prediction markets reduce the pressure to legalise.
NFL and/or UK-football renewal on materially worse terms (cost up sharply, scope split, or exclusivity lost) — 33% chance within 36 months · Impact if it happens: High
What it is: Talks for the post-2029 cycle will likely start within the window, and leagues have new bidders and direct prediction-market options.
Why it's not priced in: Consensus models run to 2028 on today's cost base.
What would trigger it / the sign to watch: an FDC tender notice, any Sportradar comment on NFL interest, or a change in the size of the £92m letter of credit.
Why this probability: Genius has renewed both twice, but the NFL's growing direct monetisation options give it more leverage than in 2021.
The earn-out is settled largely in shares at a depressed price — 45% chance · Impact: Medium
What it is: 30–50m new shares in 2027-28, adding about 11–19% to the share count.
Why it's not priced in: Consensus per-share figures typically use today's share count. The settlement choice is not announced.
What would trigger it / the sign to watch: the first tranche determination (about May 2027) and management's statement on settlement; year-end net leverage above 2×.
Why this probability: The earn-out is tracking above the closing estimate, and Genius wants to delever, but cash settlement is possible if Q4 cash lands. Close to even.
Legend traffic declines from Google/AI-search changes — 33% chance · Impact: Medium
What it is: Organic search clicks fall faster than Legend can replace them with direct and returning traffic.
Why it's not priced in: The earn-out remeasurement and management's ">20% organic" claim have set expectations of growth.
What would trigger it / the sign to watch: an earn-out remeasurement gain (meaning a lower expected payout), a goodwill impairment test flag, or peer commentary in Better Collective's Q3 (2026-11-18).
Why this probability: Peers are mixed. Legend's high returning-visitor share is a real buffer.
Customer tax squeeze forces renewal concessions (UK 25% duty from Apr 2027, US states, Brazil) — 28% chance · Impact: Medium
What it is: Large customers trade volume for price at renewal, slowing betting growth below about 15%.
Why it's not priced in: Guidance and consensus assume continued renewal price rises.
What would trigger it / the sign to watch: betting revenue growth slowing in Q3/Q4-26, or the 13% customer dropping below 10%.
Why this probability: Minimums and Genius's exclusivity limit the leverage customers have. The squeeze is broad, but a sustained concession wave is less likely than not.
Prediction markets curbed by the Supreme Court or states, removing the new growth leg — 27% chance · Impact: Low-Medium
What it is: The Court grants cert and sides with the states, or the CFTC final rule restricts sports contracts.
Why it's not priced in: Analysts (JPMorgan, Citizens) cite prediction-market upside as a reason to own the stock [22].
What would trigger it / the sign to watch: the cert decision after Kalshi's 2026-11-09 response; the CFTC final rule.
Why this probability: 39 states plus DC and the NFL back review, but a full curb within 36 months requires a merits ruling against the CFTC, which is a hard path.
| Risk area | Weight | Score (0–100) | Why |
|---|---|---|---|
| Business & competition | 25% | 53 | Still a strong position in a two-player market, but the advantage is rented, Sportradar has matched every prediction-market deal, and the NFL is not opening that door soon (+1). |
| Financial health & dilution | 20% | 62 | About $630m net debt, back-loaded cash, and an earn-out that is very dilutive if paid in shares at about $5.7. Offset by a covenant-compliant, undrawn revolver and stock compensation halving. |
| Execution (delivering the plan) | 20% | 50 | Guidance raised twice and reaffirmed after Brazil, backlog +23%, earn-out tracking. Q4 cash still unproven (−2). |
| Dependency & concentration | 15% | 66 | One customer is still 13% of revenue (now confirmed). Two league contracts carry most rights fees, and a £92m guarantee goes to one supplier. |
| Regulation, policy & geopolitics | 10% | 60 | Brazil ban (minor direct impact), UK 25% remote betting duty from Apr 2027, unresolved prediction-market jurisdiction, addiction and antitrust suits (+2). |
| Sentiment & expectations | 10% | 36 | About $5.7, roughly 7.4× guided 2026 EBITDA (EV ~$2.2bn, my arithmetic). Short interest 18.5% of float [31]. Consensus target about $11 [26]. Expectations are low; the CEO hedging cuts both ways (−2). |
Overall = 55.2 → 55 (high, just over the moderate line). The score did not change, but its mix did. Execution risk eased because the numbers available since dive #1 (backlog, revenue-share income, earn-out tracking, guidance reaffirmed) all point the right way. Dilution and insider-signal risk rose, because the Legend earn-out is expensive to settle in shares at today's price and the CEO sold and collared stock. What would move it most: Q4-26 cash, and how the earn-out is settled.